We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
1101
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $335K | ﹤0.01% |
28,371
+2,011
| +8% | +$22.6K |
|
|
PDLI
1102
DELISTED
PDL BioPharma, Inc.
PDLI
| $335K | ﹤0.01% |
98,858
+950
| +1% | +$2.64K |
|
|
CVG
1103
DELISTED
Convergys
CVG
| $334K | ﹤0.01% |
12,912
-2,463
| -16% | -$59.1K |
|
|
ODP
1104
DELISTED
ODP
ODP
| $330K | ﹤0.01% |
7,258
-1,286
| -15% | -$63.6K |
|
1105
Avanos Medical
AVNS
$1.17B
| $329K | ﹤0.01% |
7,314
-1,023
| -12% | -$43.7K |
|
|
BIG
1106
DELISTED
Big Lots, Inc.
BIG
| $329K | ﹤0.01% |
6,143
-1,208
| -16% | -$59.5K |
|
1107
American Eagle Outfitters
AEO
$2.86B
| $328K | ﹤0.01% |
22,969
-3,980
| -15% | -$48.7K |
|
1108
Chord Energy
CHRD
$7.82B
| $327K | ﹤0.01% |
35,803
-8,163
| -19% | -$64K |
|
|
DNKN
1109
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $327K | ﹤0.01% |
6,161
-629
| -9% | -$33.4K |
|
|
ESL
1110
DELISTED
Esterline Technologies
ESL
| $327K | ﹤0.01% |
3,631
-924
| -20% | -$83.3K |
|
|
B
1111
DELISTED
Barnes Group Inc.
B
| $326K | ﹤0.01% |
4,632
-554
| -11% | -$34.4K |
|
|
DST
1112
DELISTED
DST Systems Inc.
DST
| $326K | ﹤0.01% |
5,939
-643
| -10% | -$35.2K |
|
1113
Amdocs
DOX
$5.4B
| $323K | ﹤0.01% |
5,015
-448
| -8% | -$28.9K |
|
|
MNK
1114
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $323K | ﹤0.01% |
8,645
-24,476
| -74% | -$973K |
|
1115
Matador Resources
MTDR
$6.42B
| $322K | ﹤0.01% |
11,856
-3,145
| -21% | -$74.7K |
|
1116
Cars.com
CARS
$638M
| $319K | ﹤0.01% |
12,005
-2,028
| -14% | -$51.5K |
|
|
RDC
1117
DELISTED
Rowan Companies Plc
RDC
| $319K | ﹤0.01% |
24,815
-5,653
| -19% | -$60.6K |
|
1118
Carter's
CRI
$1.38B
| $317K | ﹤0.01% |
3,213
-328
| -9% | -$29.2K |
|
1119
Karyopharm Therapeutics
KPTI
$161M
| $317K | ﹤0.01% |
1,925
+115
| +6% | +$16.5K |
|
1120
Atara Biotherapeutics
ATRA
$73.6M
| $314K | ﹤0.01% |
759
+71
| +10% | +$26.8K |
|
1121
Ryder
R
$10.4B
| $314K | ﹤0.01% |
3,718
-25,107
| -87% | -$1.9M |
|
|
GWR
1122
DELISTED
Genesee & Wyoming Inc.
GWR
| $314K | ﹤0.01% |
4,238
-367
| -8% | -$25.1K |
|
1123
Grand Canyon Education
LOPE
$3.69B
| $313K | ﹤0.01% |
3,444
-920
| -21% | -$73.7K |
|
|
CAVM
1124
DELISTED
Cavium, Inc.
CAVM
| $313K | ﹤0.01% |
4,751
-312
| -6% | -$19.7K |
|
|
PAY
1125
DELISTED
Verifone Systems Inc
PAY
| $312K | ﹤0.01% |
15,391
-2,839
| -16% | -$55.4K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.